Volume 20, Issue 5, Pages (May 2012)

Slides:



Advertisements
Similar presentations
Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases Sebastian M. Dieter, Claudia R. Ball, Christopher M. Hoffmann, Ali.
Advertisements

Volume 19, Issue 2, Pages (February 2011)
Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector  Wei Huang, Travis McMurphy,
Volume 19, Issue 1, Pages (January 2011)
Volume 15, Issue 6, Pages (June 2007)
Volume 16, Issue 3, Pages (March 2008)
Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral.
Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors  Kazutoshi Takahashi, Shinya Yamanaka  Cell 
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Molecular Therapy - Nucleic Acids
Volume 26, Issue 1, Pages (January 2018)
Volume 17, Issue 11, Pages (November 2009)
Volume 9, Issue 4, Pages (October 2011)
Volume 20, Issue 7, Pages (July 2012)
Volume 17, Issue 9, Pages (September 2009)
Volume 17, Issue 8, Pages (August 2009)
Volume 12, Issue 6, Pages (December 2005)
Volume 10, Issue 3, Pages (September 2004)
Volume 14, Issue 4, Pages (October 2006)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Neeltje A Kootstra, Ryusuke Matsumura, Inder M Verma  Molecular Therapy 
Volume 29, Issue 1, Pages (April 2014)
Volume 20, Issue 5, Pages (May 2012)
Volume 23, Issue 5, Pages (May 2015)
Transduction of Human Embryonic Stem Cells by Foamy Virus Vectors
Volume 12, Issue 1, Pages (July 2005)
Volume 17, Issue 12, Pages (December 2009)
Volume 19, Issue 4, Pages (April 2011)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
Volume 12, Issue 6, Pages (December 2005)
Volume 12, Issue 3, Pages (September 2005)
Molecular Therapy - Methods & Clinical Development
Volume 19, Issue 1, Pages (January 2011)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 20, Issue 10, Pages (October 2012)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 15, Issue 9, Pages (September 2007)
Volume 28, Issue 4, Pages (April 2008)
J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell 
Volume 19, Issue 2, Pages (February 2011)
Molecular Therapy - Methods & Clinical Development
Volume 6, Issue 5, Pages (November 2002)
Volume 16, Issue 4, Pages (April 2008)
Volume 19, Issue 4, Pages (April 2011)
Volume 8, Issue 6, Pages (December 2003)
Volume 15, Issue 8, Pages (August 2007)
Volume 18, Issue 4, Pages (April 2010)
Volume 15, Issue 4, Pages (April 2007)
Volume 21, Issue 8, Pages (August 2013)
Volume 11, Issue 6, Pages (June 2005)
Volume 18, Issue 4, Pages (April 2010)
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
Volume 17, Issue 11, Pages (November 2009)
Volume 21, Issue 1, Pages (January 2013)
Molecular Therapy - Nucleic Acids
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Volume 23, Issue 4, Pages (April 2015)
Volume 19, Issue 1, Pages (January 2011)
Volume 20, Issue 6, Pages (June 2012)
Volume 17, Issue 11, Pages (November 2009)
Volume 9, Issue 5, Pages (May 2004)
Volume 11, Issue 5, Pages (May 2005)
Volume 21, Issue 5, Pages (May 2013)
Safeguarding Nonhuman Primate iPS Cells With Suicide Genes
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)  Mario Amendola, Alice Giustacchini,
Volume 15, Issue 10, Pages (October 2007)
Volume 13, Issue 1, Pages (January 2006)
Volume 17, Issue 2, Pages (February 2009)
Presentation transcript:

Volume 20, Issue 5, Pages 1014-1021 (May 2012) Extensive Methylation of Promoter Sequences Silences Lentiviral Transgene Expression During Stem Cell Differentiation In Vivo  Friederike Herbst, Claudia R Ball, Francesca Tuorto, Ali Nowrouzi, Wei Wang, Oksana Zavidij, Sebastian M Dieter, Sylvia Fessler, Franciscus van der Hoeven, Ulrich Kloz, Frank Lyko, Manfred Schmidt, Christof von Kalle, Hanno Glimm  Molecular Therapy  Volume 20, Issue 5, Pages 1014-1021 (May 2012) DOI: 10.1038/mt.2012.46 Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Functionality of Setbp1 encoding self-inactivating lentiviral vector. (a) Transcription of Setbp1 mRNA in lentiviral vector (LV)-infected murine SC1-cells (Setbp1) and in uninfected control cells (neg. Co). (b) Enhanced green fluorescent protein (eGFP)-positive SC1-cells in % after infection with LV.Setbp1 and in uninfected control cells. FSC, forward scatter. Molecular Therapy 2012 20, 1014-1021DOI: (10.1038/mt.2012.46) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Lentiviral gene transfer results in transgenic mice with single vector integrations. Lentiviral vector (LV) integration sites were detected in 65% of 31 analyzed founder (F0) mice by linear amplification-mediated (LAM)-PCR. Molecular Therapy 2012 20, 1014-1021DOI: (10.1038/mt.2012.46) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 No ectopic transgene transcription and expression in transgenic mice due to extensive methylation of spleen focus-forming virus promoter (SFFVp). (a) Genotyping-PCR analyzing tail-tip DNA of F1 mice. (b) Scheme of primer localization and reverse transcription-PCR (RT-PCR) of transgenic (Tg) and wild-type (Wt) F1 mouse whole body slices; Co, controls. (c) Peripheral blood of 49 mice was analyzed for enhanced green fluorescent protein (eGFP) expression (six representative fluorescence-activated cell sorting (FACS) blots are shown here). (d) RT-PCRs verifying transcription of genes adjacent to the proviral vector integration in progeny of three different transgenic founder mice (founder mice 323, 325, and 347). Mouse numbers in black represent transgenic mice, numbers in gray the wild-type counterparts. LV IS, lentiviral integration site. (e) Scheme of transgenic LV and the analyzed CpGs within promoter region. Heat maps for 454 reads (rows) show the methylation status of 18 CpGs (columns) within the SFFVp region in transduced control (SC1) cells and in transgenic animals (n = 8 representatives). Methylated CpGs are shown in dark gray, unmethylated CpGs in light gray and gaps in white. The average methylation level for each CpG site is visualized in the lower bar using a light gray to black color scale. FSC, forward scatter. Molecular Therapy 2012 20, 1014-1021DOI: (10.1038/mt.2012.46) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Enhanced green fluorescent protein (eGFP) expression remains stable in undifferentiated mouse embryonic stem cells (ESC) transduced with spleen focus-forming virus (SFFV) driven lentiviral vectors (LV) but decreases after spontaneous differentiation in vitro caused by promoter silencing. (a) Experimental design to assess the silencing of SFFV promoter sequences in ESC before and after spontaneous differentiation. (b) eGFP expression in undifferentiated embryonic stem cells transduced with control eGFP (G) or Setbp1 (S) encoding vector for up to 37 days after transduction. (c) Left y-axis: eGFP expression of LV transduced ESC, differentiated EB and CM (normalized to eGFP expression of ESC). Right y-axis: Relative vector copy number (VCN) determined by real-time PCR using LC480 (Roche Diagnostics) in G and in S transduced cells during differentiation. (d) Heat maps for 454 reads (rows) show the methylation status of 16 CpGs (columns) within SFFV promoter (SFFVp) in LV transduced ESC during differentiation. (e) eGFP expression (representative blots) of CM at day 4 after 5′-azacytidine (5′-AzaC) treatment (0.5 µmol/l). FSC, forward scatter. Molecular Therapy 2012 20, 1014-1021DOI: (10.1038/mt.2012.46) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Silencing of virally derived internal promoters during differentiation in lentivirally transduced embryonic and adult stem cells. (a) Enhanced green fluorescent protein (eGFP) expression over time in undifferentiated mouse embryonic stem cells (ESC) after transduction of CMV, PGK, or EF1α driven lentiviral vectors (MOI 50). (b) Percentage of eGFP+ cells during differentiation of transduced ESC with CMV, PGK, and EF1α driven lentiviral vectors. CM, cardiomyocytes; EB, embryoid bodies. (c) Heat maps for 454 reads (rows) show the methylation status of 26 CpGs (columns) within the spleen focus-forming virus promoter (SFFVp) in lentiviral vector (LV) and γ-retroviral vector (RV) backbone, 20 weeks after bone marrow transplantation. Methylated CpGs are shown in dark gray, unmethylated CpGs in light gray and gaps in white. The average methylation level for each CpG site is visualized in the lower bar using a light gray to black color scale. Molecular Therapy 2012 20, 1014-1021DOI: (10.1038/mt.2012.46) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions